Update from Dr. David Clark: Inhibitor Development in COVID-19

Written By Jen Jewell

Written by: David Clark, PhD, chair of the Coalition for Hemophilia B

The inflammation caused by COVID-19 could  possibly cause hemophilia patients to develop inhibitors. Here’s an article from Hemophilia News Today that shows that it can produce acquired hemophilia A (AHA). Acquired hemophilia is very similar to having an inhibitor. Whether it is an inhibitor against a non-hemophilic person’s  own factor VIII or factor IX, or an inhibitor against infused factor in a hemophilia  patient, the immune system decides to develop antibodies against the  factor. 

Infection by New Coronavirus Can Induce AHA, Case Report Says

Jen Jewell
Previous

Update from Dr. David Clark: What We Know and Don’t Know about COVID-19 at This Point
Next

Update from Dr. David Clark: Rebinyn and COVID-19